These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 35954298)
21. Repeated swim impairs serotonin clearance via a corticosterone-sensitive mechanism: organic cation transporter 3, the smoking gun. Baganz N; Horton R; Martin K; Holmes A; Daws LC J Neurosci; 2010 Nov; 30(45):15185-95. PubMed ID: 21068324 [TBL] [Abstract][Full Text] [Related]
22. Impairment of exocytotic transmitter release by decynium-22 through an inhibition of ion channels. Haar G; Hrachova K; Wagner T; Boehm S; Schicker K Front Pharmacol; 2023; 14():1276100. PubMed ID: 37881182 [No Abstract] [Full Text] [Related]
23. Differential Uptake Mechanisms of Fluorescent Substrates into Stem-Cell-Derived Serotonergic Neurons. Matthaeus F; Schloss P; Lau T ACS Chem Neurosci; 2015 Dec; 6(12):1906-12. PubMed ID: 26503837 [TBL] [Abstract][Full Text] [Related]
24. Brain Plasma Membrane Monoamine Transporter in Health and Disease. Vieira LS; Wang J Handb Exp Pharmacol; 2021; 266():253-280. PubMed ID: 33751232 [TBL] [Abstract][Full Text] [Related]
25. Serotonin Transporter-Independent Actions of the Antidepressant Vortioxetine As Revealed Using the SERT Met172 Mouse. Nackenoff AG; Simmler LD; Baganz NL; Pehrson AL; Sánchez C; Blakely RD ACS Chem Neurosci; 2017 May; 8(5):1092-1100. PubMed ID: 28272863 [TBL] [Abstract][Full Text] [Related]
26. Other Antidepressants. Schwasinger-Schmidt TE; Macaluso M Handb Exp Pharmacol; 2019; 250():325-355. PubMed ID: 30194544 [TBL] [Abstract][Full Text] [Related]
27. Involvement of organic cation transporter 2 inhibition in potential mechanisms of antidepressant action. Wang K; Sun S; Li L; Tu M; Jiang H Prog Neuropsychopharmacol Biol Psychiatry; 2014 Aug; 53():90-8. PubMed ID: 24657329 [TBL] [Abstract][Full Text] [Related]
29. Evidence for significant contribution of a newly identified monoamine transporter (PMAT) to serotonin uptake in the human brain. Zhou M; Engel K; Wang J Biochem Pharmacol; 2007 Jan; 73(1):147-54. PubMed ID: 17046718 [TBL] [Abstract][Full Text] [Related]
30. Impact of ovarian hormones on the modulation of the serotonin transporter by fluvoxamine. Benmansour S; Piotrowski JP; Altamirano AV; Frazer A Neuropsychopharmacology; 2009 Feb; 34(3):555-64. PubMed ID: 18322468 [TBL] [Abstract][Full Text] [Related]
31. Combined In Silico, Ex Vivo, and In Vivo Assessment of L-17, a Thiadiazine Derivative with Putative Neuro- and Cardioprotective and Antidepressant Effects. Sarapultsev A; Vassiliev P; Grinchii D; Kiss A; Mach M; Osacka J; Balloova A; Paliokha R; Kochetkov A; Sidorova L; Sarapultsev P; Chupakhin O; Rantsev M; Spasov A; Dremencov E Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948423 [TBL] [Abstract][Full Text] [Related]
32. Chronic treatment with duloxetine is necessary for an anxiolytic-like response in the mouse zero maze: the role of the serotonin transporter. Troelsen KB; Nielsen EØ; Mirza NR Psychopharmacology (Berl); 2005 Oct; 181(4):741-50. PubMed ID: 16032412 [TBL] [Abstract][Full Text] [Related]
33. The contribution of low-affinity transport mechanisms to serotonin clearance in synaptosomes. Hagan CE; Schenk JO; Neumaier JF Synapse; 2011 Oct; 65(10):1015-23. PubMed ID: 21437992 [TBL] [Abstract][Full Text] [Related]
34. Effect of antidepressants and their relative affinity for the serotonin transporter on the risk of myocardial infarction. Sauer WH; Berlin JA; Kimmel SE Circulation; 2003 Jul; 108(1):32-6. PubMed ID: 12821544 [TBL] [Abstract][Full Text] [Related]
35. Chronic fluoxetine rescues changes in plasma membrane density of 5-HT1A autoreceptors and serotonin transporters in the olfactory bulbectomy rodent model of depression. Riad M; Kobert A; Descarries L; Boye S; Rompré PP; Lacaille JC Neuroscience; 2017 Jul; 356():78-88. PubMed ID: 28528967 [TBL] [Abstract][Full Text] [Related]
37. Antidepressant-like drug effects in juvenile and adolescent mice in the tail suspension test: Relationship with hippocampal serotonin and norepinephrine transporter expression and function. Mitchell NC; Gould GG; Smolik CM; Koek W; Daws LC Front Pharmacol; 2013; 4():131. PubMed ID: 24191152 [TBL] [Abstract][Full Text] [Related]
38. Serotonin (5-HT) transporter (SERT) function after graded destruction of serotonergic neurons. Montañez S; Daws LC; Gould GG; Frazer A J Neurochem; 2003 Nov; 87(4):861-7. PubMed ID: 14622117 [TBL] [Abstract][Full Text] [Related]
39. Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice. Deltheil T; Guiard BP; Cerdan J; David DJ; Tanaka KF; Repérant C; Guilloux JP; Coudoré F; Hen R; Gardier AM Neuropharmacology; 2008 Nov; 55(6):1006-14. PubMed ID: 18761360 [TBL] [Abstract][Full Text] [Related]
40. Interspecies comparison of the functional characteristics of plasma membrane monoamine transporter (PMAT) between human, rat and mouse. Shirasaka Y; Lee N; Duan H; Ho H; Pak J; Wang J J Chem Neuroanat; 2017 Oct; 83-84():99-106. PubMed ID: 27641077 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]